Esperion Therapeutics, Inc. (ESPR) Social Stream
ESPERION THERAPEUTICS INC (ESPR) Price Targets From Analysts
Use the tables below to see what analysts covering ESPERION THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 8 | $114 | $8 | $35.375 | $2.33 | 1418.24% |
| 2021-12-09 | 8 | $90 | $8 | $22.625 | $2.33 | 871.03% |
| 2021-12-22 | 8 | $90 | $5 | $22.125 | $2.33 | 849.57% |
| 2021-12-23 | 8 | $30 | $5 | $13.75 | $2.33 | 490.13% |
| 2022-01-05 | 8 | $30 | $5 | $13.5 | $2.33 | 479.4% |
| 2022-01-11 | 8 | $30 | $5 | $12.875 | $2.33 | 452.58% |
| 2022-01-21 | 8 | $30 | $4 | $12.5 | $2.33 | 436.48% |
| 2022-01-28 | 8 | $27 | $4 | $10.625 | $2.33 | 356.01% |
| 2022-01-31 | 8 | $27 | $4 | $10.25 | $2.33 | 339.91% |
| 2022-02-25 | 8 | $27 | $4 | $10.857 | $2.33 | 365.97% |
| 2022-03-10 | 9 | $27 | $4 | $12.25 | $2.33 | 425.75% |
| 2022-05-04 | 8 | $27 | $4 | $12.857 | $2.33 | 451.8% |
| 2022-05-05 | 8 | $27 | $5 | $12.25 | $2.33 | 425.75% |
| 2022-08-03 | 8 | $27 | $3 | $11.444 | $2.33 | 391.16% |
| 2022-10-12 | 8 | $27 | $3 | $11.222 | $2.33 | 381.63% |
| 2022-11-02 | 8 | $27 | $3 | $11.333 | $2.33 | 386.39% |
| 2022-11-09 | 8 | $27 | $3 | $12 | $2.33 | 415.02% |
| 2022-12-07 | 8 | $22 | $3 | $9.857 | $2.33 | 323.05% |
| 2022-12-20 | 8 | $22 | $3 | $9.75 | $2.33 | 318.45% |
| 2023-01-10 | 8 | $22 | $3 | $9.75 | $2.33 | 318.45% |
| 2023-02-22 | 8 | $22 | $3 | $10.285 | $2.33 | 341.42% |
| 2023-02-24 | 9 | $22 | $3 | $10.5 | $2.33 | 350.64% |
| 2023-03-06 | 10 | $22 | $3 | $11.555 | $2.33 | 395.92% |
| 2023-03-16 | 10 | $22 | $1.5 | $10.55 | $2.33 | 352.79% |
| 2023-03-17 | 10 | $22 | $1 | $9.55 | $2.33 | 309.87% |
| 2023-03-24 | 10 | $22 | $1 | $9.6 | $2.33 | 312.02% |
| 2023-04-18 | 10 | $22 | $1 | $9.2 | $2.33 | 294.85% |
| 2023-05-09 | 9 | $22 | $1 | $9.8 | $2.33 | 320.6% |
| 2023-05-11 | 9 | $22 | $1 | $10.025 | $2.33 | 330.26% |
| 2023-06-06 | 8 | $22 | $1 | $10.025 | $2.33 | 330.26% |
| 2023-06-26 | 7 | $22 | $1 | $10.571 | $2.33 | 353.69% |
| 2023-08-01 | 7 | $22 | $1 | $10.571 | $2.33 | 353.69% |
| 2023-11-08 | 9 | $22 | $2 | $8.857 | $2.33 | 280.13% |
The Trend in the Analyst Price Target
Over the past 13 months, ESPR's average price target has gone down $2.37.
Over the past 43 weeks, ESPR's average upside potential has been 475.62%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-21 | 8 | 22 | 3 | 9.750 | 5.590 | 74.42% |
| 2023-03-06 | 10 | 22 | 3 | 11.555 | 5.075 | 127.68% |
| 2023-04-18 | 10 | 22 | 1 | 9.200 | 1.320 | 596.97% |
| 2023-05-11 | 9 | 22 | 1 | 10.025 | 1.490 | 572.82% |
| 2023-08-01 | 7 | 22 | 1 | 10.571 | 1.690 | 525.5% |
ESPR Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 5 | 1 | 2 | 1 | 1 | 9 |
The Trend in the Broker Recommendations
Over the past 19 months, ESPR's average broker recommendation rating improved by 1.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- ESPERION THERAPEUTICS INC's variance in analysts' estimates is lower than -4042.82% of all US stocks.
- In terms of how ESPERION THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 3911.67% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ESPERION THERAPEUTICS INC's average analyst price target is greater than 591.69% of them.
- ESPERION THERAPEUTICS INC's number of analysts covering the stock is higher than 2443.86% of Pharmaceutical Products stocks.
Stocks similar to ESPERION THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PBYI, PCRX, and EBS.
View All Top Stocks by Price Target
Is ESPR a Buy, Hold or Sell? See the POWR Ratings now!